# Evaluation of the Interactions of Cannabidiol (CBD) With Morphine

> **NCT05143424** · PHASE1 · UNKNOWN · sponsor: **National Institute on Drug Abuse (NIDA)** · enrollment: 60 (estimated)

## Conditions studied

- Opioid Use Disorder

## Interventions

- **DRUG:** Morphine Sulfate

## Key facts

- **NCT ID:** NCT05143424
- **Lead sponsor:** National Institute on Drug Abuse (NIDA)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-11-04
- **Primary completion:** 2023-09-01
- **Final completion:** 2024-12-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2024-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05143424

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05143424, "Evaluation of the Interactions of Cannabidiol (CBD) With Morphine". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT05143424. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*